FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.
FMC secures a $400 million investment from Tessenderlo Group to cut debt, strengthen liquidity and support crop protection technology growth.
FMC plans a $114M Newark property sale to cut debt, retain key R&D operations and keep its Stine Research Center fully intact.
FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.
FMC Corporation (FMC) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript
FMC (FMC) reported earnings 30 days ago. What's next for the stock?
FMC Corporation (FMC) Presents at 21st Annual Global Farm to Market Conference Transcript
FMC Corporation (FMC) Q1 2026 Earnings Call Transcript
FMC beat Q1 revenue and loss estimates as volume gains and FX tailwinds offset pricing pressure, while it reaffirmed its 2026 outlook.
FMC (FMC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to earnings of $0.18 per share a year ago.
FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC wins EU approval for Isoflex herbicide, unlocking access to more than 55 million hectares in a market lacking new crop protection solutions.